Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, August 11, 2022.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Crossroads (+60) - ACAD is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid ACAD?
MarketClub looks at technical strength and momentum to determine if the timing is right for ACAD.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ACAD
The long-term trend has been DOWN since Apr 22nd, 2022 at 20.740
The intermediate-term trend has been UP since Aug 5th, 2022 at 16.265
The short-term trend has been UP since Aug 3rd, 2022 at 15.060
Smart Scan Analysis for ACAD
Based on our trend formula, ACAD is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 16.11 | 16.28 | 15.56 | 15.74 | -0.41 |
| Prev. Close | Volume | Bid | Ask | Time |
| 16.15 | 933495 | 2022-08-11 15:59:57 |
| Year High | 32.99 | Year High Date | 2018-01-29 |
| Year Low | 12.77 | Year Low Date | 2018-08-09 |
| 52wk High | 28.055 | 52wk High Date | 2022-04-07 |
| 52wk Low | 12.24 | 52wk Low Date | 2022-06-21 |
| Year End Close | 4.65 | Average Volume | 1,860,477 |
| Shares Outstanding | 161,843 | Short Interest | 3,525,887 |
| % Institutional | 92.8 | Market Cap | 5,980M |
| Assets | 624,251,000M | Liabilities | 179,454,000M |
| P/E Ratio | -9.78200000 | Beta | 3.11 |
| Volatility | 108.39 |